PGIM Jennison Emerging Markets Equity Opportunities Fund
Schedule of Investments as of January 31, 2021 (unaudited)
Description | Shares | Value | |||
Long-Term Investments 92.8% | |||||
Common Stocks | |||||
Argentina 8.0% | |||||
Globant SA* | 16,630 | $3,192,960 | |||
MercadoLibre, Inc.* | 5,912 | 10,520,463 | |||
13,713,423 | |||||
Brazil 2.7% | |||||
Magazine Luiza SA | 1,000,752 | 4,594,599 | |||
China 47.3% | |||||
Aier Eye Hospital Group Co. Ltd. (Class A Stock) | 321,167 | 3,914,962 | |||
BeiGene Ltd., ADR* | 5,259 | 1,682,880 | |||
Bilibili, Inc., ADR* | 70,357 | 8,012,959 | |||
Burning Rock Biotech Ltd., ADR* | 52,950 | 1,597,501 | |||
Contemporary Amperex Technology Co. Ltd. (Class A Stock) | 105,716 | 5,790,861 | |||
Genetron Holdings Ltd., ADR* | 99,785 | 2,300,044 | |||
Glodon Co. Ltd. (Class A Stock) | 276,229 | 3,551,153 | |||
Hangzhou Tigermed Consulting Co. Ltd. (Class H Stock), 144A* | 140,504 | 3,099,571 | |||
Hygeia Healthcare Holdings Co. Ltd., 144A* | 236,367 | 1,825,233 | |||
Innovent Biologics, Inc., 144A* | 274,311 | 3,127,436 | |||
Jiangsu Hengrui Medicine Co. Ltd. (Class A Stock) | 138,426 | 2,224,259 | |||
Kuaishou Technology (Class B Stock), 144A* | 7,000 | 103,827 | |||
Li Ning Co. Ltd. | 579,379 | 3,633,543 | |||
Meituan (Class B Stock)* | 89,239 | 4,082,376 | |||
Silergy Corp. | 48,000 | 4,479,005 | |||
Tencent Holdings Ltd. | 65,415 | 5,759,831 | |||
Weimob, Inc., 144A*(a) | 1,827,752 | 5,261,770 | |||
Wuliangye Yibin Co. Ltd. (Class A Stock) | 92,805 | 4,176,277 | |||
WuXi AppTec Co. Ltd. (Class H Stock), 144A | 166,743 | 3,986,378 | |||
Wuxi Biologics Cayman, Inc., 144A* | 538,541 | 7,582,312 | |||
Zai Lab Ltd., ADR* | 27,931 | 4,470,915 | |||
80,663,093 | |||||
India 13.8% | |||||
Ashok Leyland Ltd. | 3,304,454 | 5,013,443 | |||
Asian Paints Ltd. | 86,460 | 2,854,082 | |||
Divi’s Laboratories Ltd. | 52,005 | 2,405,172 | |||
HDFC Bank Ltd., ADR* | 55,886 | 4,029,381 | |||
Hindustan Unilever Ltd. | 91,786 | 2,847,551 | |||
MakeMyTrip Ltd.* | 119,806 | 3,418,065 | |||
Titan Co. Ltd. | 151,564 | 2,945,052 | |||
23,512,746 |
1
PGIM Jennison Emerging Markets Equity Opportunities Fund
Schedule of Investments as of January 31, 2021 (unaudited) (continued)
Description | Shares | Value | |||
Common Stocks (Continued) | |||||
Poland 1.3% | |||||
Dino Polska SA, 144A* | 31,642 | $2,230,960 | |||
South Korea 7.1% | |||||
Kakao Corp.* | 6,890 | 2,706,022 | |||
NAVER Corp. | 9,286 | 2,831,304 | |||
Samsung SDI Co. Ltd. | 10,059 | 6,576,352 | |||
12,113,678 | |||||
Taiwan 11.4% | |||||
MediaTek, Inc. | 88,000 | 2,749,191 | |||
Sea Ltd., ADR* | 51,943 | 11,256,567 | |||
Taiwan Semiconductor Manufacturing Co. Ltd., ADR | 44,534 | 5,411,772 | |||
19,417,530 | |||||
Thailand 1.2% | |||||
Minor International PCL* | 2,551,435 | 2,106,921 | |||
Total Long-Term Investments (cost $117,982,383) | 158,352,950 | ||||
Short-Term Investments 13.4% | |||||
Affiliated Mutual Funds | |||||
PGIM Core Ultra Short Bond Fund(wa) | 17,771,371 | 17,771,371 | |||
PGIM Institutional Money Market Fund (cost $5,115,280; includes $5,114,988 of cash collateral for securities on loan)(b)(wa) | 5,117,610 | 5,115,563 | |||
Total Short-Term Investments (cost $22,886,651) | 22,886,934 | ||||
TOTAL INVESTMENTS 106.2% (cost $140,869,034) | 181,239,884 | ||||
Liabilities in excess of other assets (6.2)% | (10,553,294) | ||||
Net Assets 100.0% | $170,686,590 |
Below is a list of the abbreviation(s) used in the quarterly schedule of portfolio holdings: |
144A—Security was purchased pursuant to Rule 144A under the Securities Act of 1933 and, pursuant to the requirements of Rule 144A, may not be resold except to qualified institutional buyers. | |
ADR—American Depositary Receipt |
* | Non-income producing security. |
2
PGIM Jennison Emerging Markets Equity Opportunities Fund
Schedule of Investments as of January 31, 2021 (unaudited) (continued)
(a) | All or a portion of security is on loan. The aggregate market value of such securities, including those sold and pending settlement, is $5,000,742; cash collateral of $5,114,988 (included in liabilities) was received with which the Series purchased highly liquid short-term investments. In the event of significant appreciation in value of securities on loan on the last business day of the reporting period, the Series may reflect a collateral value that is less than the market value of the loaned securities and such shortfall is remedied the following business day. |
(b) | Represents security, or portion thereof, purchased with cash collateral received for securities on loan and includes dividend reinvestment. |
(wa) | PGIM Investments LLC, the manager of the Series, also serves as manager of the PGIM Core Ultra Short Bond Fund and PGIM Institutional Money Market Fund, if applicable. |
Other information regarding the Series is available in the Series’ most recent Report to Shareholders. This information is available on the Securities and Exchange Commission’s website (www.sec.gov).
3